Vaxart Inc (VXRT)
0.601
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 15:01
Vaxart Enterprise Value: 77.62M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 77.62M |
| November 20, 2024 | 79.55M |
| November 19, 2024 | 82.33M |
| November 18, 2024 | 80.05M |
| November 15, 2024 | 73.25M |
| November 14, 2024 | 84.60M |
| November 13, 2024 | 103.78M |
| November 12, 2024 | 105.57M |
| November 11, 2024 | 99.11M |
| November 08, 2024 | 97.23M |
| November 07, 2024 | 105.64M |
| November 06, 2024 | 101.94M |
| November 05, 2024 | 107.78M |
| November 04, 2024 | 106.21M |
| November 01, 2024 | 116.42M |
| October 31, 2024 | 115.38M |
| October 30, 2024 | 119.84M |
| October 29, 2024 | 122.25M |
| October 28, 2024 | 131.25M |
| October 25, 2024 | 128.57M |
| October 24, 2024 | 118.27M |
| October 23, 2024 | 118.56M |
| October 22, 2024 | 120.84M |
| October 21, 2024 | 119.52M |
| October 18, 2024 | 127.75M |
| Date | Value |
|---|---|
| October 17, 2024 | 125.18M |
| October 16, 2024 | 126.64M |
| October 15, 2024 | 120.11M |
| October 14, 2024 | 117.36M |
| October 11, 2024 | 120.11M |
| October 10, 2024 | 121.31M |
| October 09, 2024 | 123.29M |
| October 08, 2024 | 119.36M |
| October 07, 2024 | 125.32M |
| October 04, 2024 | 126.07M |
| October 03, 2024 | 128.07M |
| October 02, 2024 | 137.44M |
| October 01, 2024 | 128.50M |
| September 30, 2024 | 134.42M |
| September 27, 2024 | 124.16M |
| September 26, 2024 | 121.18M |
| September 25, 2024 | 116.63M |
| September 24, 2024 | 128.43M |
| September 23, 2024 | 127.68M |
| September 20, 2024 | 127.18M |
| September 19, 2024 | 143.49M |
| September 18, 2024 | 142.13M |
| September 17, 2024 | 147.67M |
| September 16, 2024 | 151.18M |
| September 13, 2024 | 161.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-16.37M
Minimum
Dec 27 2022
2.446B
Maximum
Feb 02 2021
321.18M
Average
161.15M
Median
Feb 07 2024
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 9.017M |
| Perspective Therapeutics Inc | -63.40M |
| Protalix BioTherapeutics Inc | 94.82M |
| Electromed Inc | 223.55M |
| Armata Pharmaceuticals Inc | 166.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.08M |
| Revenue (Quarterly) | 4.933M |
| Total Expenses (Quarterly) | 19.41M |
| EPS Diluted (Quarterly) | -0.06 |
| Profit Margin (Quarterly) | -285.4% |
| Earnings Yield | -68.22% |
| Normalized Earnings Yield | -68.22 |